ICYMI: The 10 Best Health Stories from August


The MD Magazine editors rounded up the 10 best stories from August – did you read them all?

primary care, family medicine, internal medicine, cardiology, endocrinology, gastroenterology, psychiatry, neurology, rheumatology, hospital medicine, infectious disease, pain management, OBGYN, women’s health, men’s health, pulmonology

The summer months are coming to an end and it is almost time for all things autumn! But before we jump into that, the editors at MD Magazine rounded up the best stories from August. So if you were busy taking a much needed break (or working on your tan), here are the top pieces that you need to catch up on — including an interview with an Olympic soccer star!

Don’t forget to stay up-to-date by connecting with us on Facebook, Twitter, Instagram, and LinkedIn!

Although indications for medicinal marijuana differ by state, pain is a common condition behind a prescription. But pain relief effects of cannabis differ by gender, according to a new study from Columbia University Medical Center (CUMC), and one reaps more of the benefits.

>>> Continue reading this story.

MD Magazine spoke with world-renowned soccer star, Brandi Chastain, who recently partnered with AbbVie on a new advocacy campaign, My IBD Game Plan, in the wake of her son’s Crohn’s disease diagnosis. Millie Long, MD, MPH associate professor of medicine in the Division of Gastroenterology and Hepatology at The University of North Carolina (UNC) Chapel Hill School of Medicine, shared the clinical landscape and management methods for the condition.

>>> Read the exclusive interview with Brandi Chastain.

An outbreak of hepatitis C in mostly young, white, suburban heroin users who living in or near Princton, NJ, made headlines after it was reported October 7, 2015 at ID Week 2015 in San Diego, CA. Ronald Nahass, MD, was a co-author of the ID Week study.

>>> Read the exclusive interview with Ronald Nahass, MD.

Whether it is obstructive or central sleep apnea or any number of other conditions finding the right treatment method can make a big difference in improving quality of life.

While traditional machine like CPAPs can be difficult to work at first, Kimberly A. Hardin, MD, from UC Davis Health System said there are potential adjustments that can be made to help patients adjust to their new way of sleeping.

>>> Watch the exclusive interview with Kimberly Hardin, MD.

It’s no secret that prescription drug misuse and abuse are on the rise. In an effort to curb addiction, researchers aimed to find how physician prescribing patterns influence the number of new cases.

>>> Continue reading this story.

Calcium supplements may seem to be a safe and effective method to manage osteoporosis, but regular consumption of these pills could increase the risk of dementia in women, specifically those who have experienced cerebrovascular diseases or poor blood flow to the brain, or have suffered a stroke.

>>> Continue reading this story.

The blistering pace of mobile innovation has opened countless doors for clinical application. Built on Apple’s ResearchKit platform, GlaxoSmithKline recently launched an app-based study called Patient Rheumatoid Arthritis Data from the Real World (PARADE). Designed to collect real-life pain and quality-of-life data from RA sufferers without requiring clinic visits, the study will track 300 patients over three months.

>>> Continue reading this story.

Zika infection could put adults at risk of dementia and other neurological diseases and is likely even more dangerous than first thought, researchers at The Rockefeller University and La Jolla Institute for Allergy and Immunology report.

>>> Continue reading this story.

The good news is that hepatitis C is largely a curable disease. The bad news is that many of the most advanced medications are accompanied by a heavy price tag. Despite that, a survey on the physician social networking site, SERMO, revealed that nearly two-thirds of doctors say that drugs are worth the cost.

>>> Continue reading this story.

Typically, the creation of a new drug is a process of tweaking or combining the existing drugs to alter outcomes and side effects. A recent collaboration between researchers from Germany and across the United States, however, takes a novel approach in the battle against opiate addiction: trying to build a new painkiller from scratch.

>>> Continue reading this story.

Related Videos
Ankeet Bhatt, MD, MBA | Credit: X.com
Ankeet Bhatt, MD, MBA | Credit: X.com
Sara Saberi, MD | Credit: University of Michigan
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Albert Foa, MD, PhD | Credit: HCPLive
Veraprapas Kittipibul, MD | Credit: X.com
© 2024 MJH Life Sciences

All rights reserved.